Tofacitinib, a suppressor of NOD2 expression, is a potential treatment for Blau syndrome

por Ueki, Yoko, Takimoto-Ito, Riko, Saito, Megumu K., Tanizaki, Hideaki, Kambe, Naotomo
Publicado 2023

Potential Benefits of TNF Targeting Therapy in Blau Syndrome, a NOD2-Associated Systemic Autoinflammatory Granulomatosis

por Matsuda, Tomoko, Kambe, Naotomo, Takimoto-Ito, Riko, Ueki, Yoko, Nakamizo, Satoshi, Saito, Megumu K., Takei, Syuji, Kanazawa, Nobuo
Publicado 2022

Activation of the pentose phosphate pathway in macrophages is crucial for granuloma formation in sarcoidosis

por Nakamizo, Satoshi, Sugiura, Yuki, Ishida, Yoshihiro, Ueki, Yoko, Yonekura, Satoru, Tanizaki, Hideaki, Date, Hiroshi, Yoshizawa, Akihiko, Murata, Teruasa, Minatoya, Kenji, Katagiri, Mikako, Nomura, Seitaro, Komuro, Issei, Ogawa, Seishi, Nakajima, Saeko, Kambe, Naotomo, Egawa, Gyohei, Kabashima, Kenji
Publicado 2023